COVID19 Cold War: Will the 2nd Wave Come from Vaccine Trials

In the fast-track system, a pharmaceutical company hardly examines the results of a phase one trial before moving on to phases two and three. | Photo: NIAID

By Dady Chery
Telesur

An FDA “fast-track” designation has essentially accorded a carte blanche to a set of vaccines that are financed by CEPI, an alliance of Bill Gates with the six biggest pharmaceutical companies

If the English-language press had done its job, and not parroted press releases that promote vaccination as the only escape from the social isolation we’ve endured the last three months, the public would be asking many questions about the ongoing protests and their relation to the logistics of vaccine trials. To test a vaccine, typically a pharmaceutical company recruits healthy volunteers for several phases of a clinical trial with a defined endpoint.

I have previously noted that an FDA “fast-track” designation has essentially accorded a carte blanche to…